Page last updated: 2024-10-25

deferiprone and Ischemia

deferiprone has been researched along with Ischemia in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Thapa, K1
Singh, TG1
Kaur, A1
Reuter, DG1
Tacker, WA1
Babbs, CF1
Badylak, SF1
Voorhees, WD1
Konrad, PE1

Reviews

1 review available for deferiprone and Ischemia

ArticleYear
Targeting ferroptosis in ischemia/reperfusion renal injury.
    Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:11

    Topics: Deferasirox; Deferiprone; Ferroptosis; Humans; Iron; Iron Chelating Agents; Ischemia; Kidney; Pharma

2022

Other Studies

1 other study available for deferiprone and Ischemia

ArticleYear
Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia.
    The Journal of thoracic and cardiovascular surgery, 1995, Volume: 109, Issue:5

    Topics: Animals; Deferiprone; Deferoxamine; Dogs; Iron Chelating Agents; Ischemia; Pyridones; Reperfusion In

1995